logo

Arqule Inc. (ARQL)



Trade ARQL now with
  Date
  Headline
10/31/2018 7:03:44 AM ArQule Q3 Net Loss $5.62 Mln Or $0.05/Shr Vs Loss Of $6.67 Mln Or $0.09/Shr Last Year
10/19/2018 7:04:39 AM ArQule Presents Orphan Disease Clinical Data At ASHG 2018 Annual Meeting
9/13/2018 7:04:15 AM ArQule Says Miransertib Granted Fast Track Designation For Treatment Of PIK3CA-Related Overgrowth Spectrum
8/1/2018 7:04:27 AM ArQule Q2 EPS $0.05 Vs Loss $0.10 Last Year
7/11/2018 7:00:53 AM ArQule Prices Public Offering Of 11 Mln Common Shares At $5.50 Per Share
7/10/2018 4:13:37 PM ArQule Commences Proposed Public Offering Of Common Stock
6/15/2018 7:00:49 AM ArQule Presents Results From Ongoing Phase 1 Dose Escalation Study Of Reversible BTK Inhibitor, ARQ 531
6/7/2018 7:00:42 AM ArQule To Present Clinical Data For Its BTK Inhibitor, ARQ 531
5/24/2018 7:06:22 AM ArQule Announces Two Key Appointments